Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial. (nature.com)

Authors: Lee CK … Choi HJ Journal: Nature Medicine Published: 2026-09-22 DOI: https://doi.org/10.1038/s41591-026-04679-x